Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

22.33
Delayed Data
As of 4:00pm ET
 +0.40 / +1.82%
Today’s Change
10.00
Today|||52-Week Range
22.96
+49.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization516.0K673.0K662.0K156.00
 
 
 
 
 
 
Operating ExpensesGross Income-516.0K-673.0K-662.0K-156.00
 
 
 
 
 
General Expenses87.0M83.3M66.9M25.0M
 
 
 
 
 
Research And Development71.9M68.2M54.2M15.9M
 
 
 
 
 
Total Operating Expenses87.6M84.0M67.6M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-87.6M-84.0M-67.6M-25.0M
 
 
 
 
 
Extraordinary Charge0.00--0.00-242.0K
 
 
Interest Expense On Debt2.6M2.2M1.1M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-90.2M-86.2M-68.7M-26.4M
 
 
 
 
 
Net Income-90.2M-86.2M-68.7M-26.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.8M--5.2M
 
 
 
 
Shares To Calculate EPS Diluted2.0M2.8M--5.2M
 
 
 
 
 
Earnings Per ShareEPS-$44.45-$30.45---$5.07
 
 
 
 
EPS Diluted-$44.45-$30.45---$5.07